Harrow
Commercializes branded eye medicines and ImprimisRx compounding for US ophthalmology.
$37.77
After-hours close+0.48 (+1.29%)
At close$37.29(−3.24%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.16 | — | — |
| Aug 2026 | −$0.18 | −$0.46 | −157.3% |
| May 2026 | −$0.43 | −$0.63 | −46.5% |
| Mar 2026 | $0.40 | $0.26 | −35.0% |
| Nov 2025 | $0.22 | $0.33 | +50.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | $0.16 | — | — | $98.7M | — | — |
| Aug 10, 2026 | −$0.18 | −$0.46 | −157.3% | $70.4M | $70.7M | +0.4% |
| May 11, 2026 | −$0.43 | −$0.63 | −46.5% | $52.4M | $44.2M | −15.7% |
| Mar 2, 2026 | $0.40 | $0.26 | −35.0% | $90.0M | $89.1M | −1.0% |
| Nov 10, 2025 | $0.22 | $0.33 | +50.0% | $88.0M | $71.6M | −18.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 27, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 13, 2024 | ||||||
| Mar 19, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 5, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 10, 2021 | ||||||
| May 11, 2021 | ||||||
| Mar 8, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 11, 2020 | ||||||
| Mar 13, 2020 | ||||||
| Nov 13, 2019 | ||||||
| Aug 14, 2019 | ||||||
| May 9, 2019 | ||||||
| Mar 12, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 6, 2018 | ||||||
| May 15, 2018 | ||||||
| Mar 9, 2018 | ||||||
| Nov 14, 2017 | ||||||
| Aug 10, 2017 | ||||||
| May 10, 2017 | ||||||
| Mar 21, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Aug 15, 2016 | ||||||
| May 12, 2016 | ||||||
| Mar 23, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Aug 12, 2015 | ||||||